Forget buy-to-let, I’d buy shares in these property companies instead

These two shares could outperform buy-to-let in the long run.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While buy-to-let has been a relatively obvious choice for investors in the past, its appeal seems to be declining. An era of low interest rates could be coming to an end, with a tighter monetary policy forecast.

This could squeeze the cash flow of landlords at a time when rental growth may be limited by the UK’s economic uncertainty. And with house prices having the potential to fall depending on how the Brexit process moves ahead, being a landlord may become even less attractive.

With that in mind, here are two property-related shares which could be of interest. They appear to offer improving prospects and could generate higher returns than buy-to-let in the long run. As such, they could be worth buying in my opinion.

Growth potential

Releasing an update on Friday was UK healthcare real estate investor Impact Healthcare (LSE: IHR). The real estate investment trust (REIT) updated investors on pipeline acquisitions. It had previously announced that it was in advanced negotiations to acquire an identified pipeline of attractive investment opportunities which included a portfolio of UK care homes with over 2,500 beds.

However, it has now decided not to exchange contracts on the portfolio of assets during 2018. It will therefore not require an equity fundraising prior to the year end. It will, though, remain in discussions with the vendors of the portfolio and with other vendors of other attractive investment opportunities. It therefore expects to raise equity capital at some point in 2019.

The prospects for Impact Healthcare appear to be generally positive. An ageing population and increasing spending on the healthcare sector could lead to a tailwind for the industry in future. With the stock offering a relatively resilient outlook and a price-to-book (P/B) ratio of around 1, it could offer investment appeal for the long run in my opinion.

Total returns

The prospects for another REIT, Big Yellow Group (LSE: BYG), may also be relatively impressive. It has a dominant position in the self-storage sector, and this could provide it with a competitive advantage in terms of cost base and customer loyalty. It has relatively attractive locations, and its strategy suggests that further growth could be ahead over the long run.

The stock has experienced a period of volatility in recent months – in line with other FTSE 250 stocks which have a UK focus during the same time period. It now offers a dividend yield of around 3.9%, which is ahead of the FTSE 250’s yield of 3%. The company’s track record of dividend growth is impressive. It has been able to raise dividends per share at an annualised rate of 17% in the last four years. Although future dividend growth may not live up to its past increase, the performance of the business could remain sound.

Looking ahead, Big Yellow Group is expected to report a rise in earnings of 8% next year. Although the outlook for the UK economy may be uncertain, it could deliver impressive total returns in the long run.

Peter Stephens has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Down 35% in 2 months! Should I buy NIO stock at $5?

NIO stock has plunged in recent weeks, losing a third of its market value despite surging sales. Is this EV…

Read more »

Two employees sat at desk welcoming customer to a Tesla car showroom
Investing Articles

Could 2026 be the year when Tesla stock implodes?

Tesla's 2025 business performance has been uneven. But Tesla stock has performed well overall and more than doubled since April.…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Could these FTSE 100 losers be among the best stocks to buy in 2026?

In the absence of any disasters, Paul Summers wonders if some of the worst-performing shares in FTSE 100 this year…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

Up 184% this year, what might this FTSE 100 share do in 2026?

This FTSE 100 share has almost tripled in value since the start of the year. Our writer explains why --…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

You can save £100 a month for 30 years to target a £2,000 a year second income, or…

It’s never too early – or too late – to start working on building a second income. But there’s a…

Read more »

Hydrogen testing at DLR Cologne
Investing Articles

Forget Rolls-Royce shares! 2 FTSE 100 stocks tipped to soar in 2026

Rolls-Royce's share price is expected to slow rapidly after 2025's stunning gains. Here are two top FTSE 100 shares now…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

Brokers think this 83p FTSE 100 stock could soar 40% next year!

Mark Hartley takes a look at the factors driving high expectations for one major FTSE 100 retail stock – is…

Read more »

Investing Articles

I asked ChatGPT for the best FTSE 100 shares to consider for 2026, and it said…

Whatever an individual investor's favourite strategy, I reckon there's something for everyone among the shares in the FTSE 100.

Read more »